IP Library Assignment 018423/0616
Patent Assignment
Reel/Frame 018423/0616

Assignment of Assignor's Interest

Recorded: 2006-10-06 Pages: 10
Assignors
DYMOCK, BRIAN WILLIAM
Executed: 2006-08-22
DRYSDALE, MARTIN JAMES
Executed: 2006-05-22
FROMONT, CHRISTOFE
Executed: 2006-05-16
JORDAN, ALLAN
Executed: 2006-05-15
BARRIL-ALONSO, XAVIER
Executed: 2006-05-24
Assignees
VERNALIS (CAMBRIDGE) LIMITED
GRANTA PARK, ABINGTON, CAMBRIDGE, CB1 6GB, GREAT BRITAIN
CANCER RESEARCH TECHNOLOGY LTD.
61 LINCOLN'S INN FIELDS, LONDON, WC2A 3PX, GREAT BRITAIN
INSTITUTE OF CANCER RESEARCH, THE
ROYAL CANCER HOSPITAL, 123 OLD BROMPTON ROAD, LONDON, SW7 3RP, GREAT BRITAIN
BARRIL-ALONSO, XAVIER
VERNALIS (CAMBRIDGE) LIMITED, GRANTA PARK, ABINGTON, CAMBRIDGE, CB1 6GB, GREAT BRITAIN
Covered Property (1)
Substituted Thieno[2,3-D]Pyrimidines as HSP90 Inhibitors
Patent: 7,820,658 →
Application: 10/569,287 →
Publication: US 2007/0043044
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 12, 2012
From: VERNALIS (CAMBRIDGE) LIMITED
To: VERNALIS (R&D) LIMITED
Reel/Frame 029450/0945 →